Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Obstet Gynecol. 2012 Feb;119(2 Pt 1):286–292. doi: 10.1097/AOG.0b013e318240de51

Table 6.

Complications and Adverse Events by Risk-Group Membership

Low
n = 389
High
n = 582
Test Statistic (P)
Intraoperative complications
   Any 7.5 (29) 10.1 (59) 0.154
   Bowel 1.0 (4) 2.7 (16) 0.064
   Veins 2.3 (9) 3.1 (18) 0.469
   Artery 1.3 (5) 1.4 (8) 0.906
   Gastrointestinal tract 0.0 (0) 0.7 (4) 0.101
   Bladder 0.8 (3) 1.5 (9) 0.284
   Ureter 0.8 (3) 0.9 (5) 0.882
   Other 1.3 (5) 1.7 (10) 0.592
Postoperative adverse events (grade 2 or higher)
   Any 11.1 (43) 16.0 (93) 0.030
   Urinary tract infection 2.3 (9) 2.2 (13) 0.935
   Fever 2.6 (10) 3.1 (18) 0.634
   Pelvic cellulitis 1.0 (4) 1.4 (8) 0.632
   Abscess 1.0 (4) 1.2 (7) 0.801
   Venous thrombophlebitis 0.8 (3) 0.9 (5) 0.882
   Pulmonary embolus 0.5 (2) 1.0 (6) 0.383
   Bowel obstruction 0.8 (3) 0.5 (3) 0.618
   Ileus 3.1 (12) 3.6 (21) 0.659
   Pneumonia 0.5 (2) 1.2 (7) 0.273
   Wound infection 2.1 (8) 2.9 (17) 0.405
   Urinary fistula 0.5 (2) 0.2 (1) 0.346
   Bowel fistula 0.0 (0) 0.9 (5) 0.067
   Congestive heart failure 0.3 (1) 0.3 (2) 0.812
   Arrhythmia 1.0 (4) 1.0 (6) 0.997
Perioperative and postoperative period
   Blood transfusion 1.3 (5) 3.1 (18) 0.070
   Antibiotics 14.1 (55) 17.2 (100) 0.205
   Readmission 4.9 (19) 5.0 (29) 0.945
   Reoperation 1.0 (4) 1.9 (11) 0.286
   Treatment-related deaths 0.5 (2) 0.2 (1) 0.346
   Hospital stay more than 2 days 55.5 (216) 63.7 (371) 0.010

Data are percent (frequency) unless otherwise specified.